Cargando…
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
Federal regulatory changes during the COVID-19 pandemic allow buprenorphine to be prescribed without an initial in-person evaluation. Prior to COVID-19, numerous barriers limited broad uptake of buprenorphine among people who use drugs at the system, provider, and patient levels, including lack of a...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833481/ https://www.ncbi.nlm.nih.gov/pubmed/33771276 http://dx.doi.org/10.1016/j.jsat.2020.108272 |